New Protocol: Trastuzumab deruxtecan for her2+ metastatic colorectal cancer
|New Protocol: Trastuzumab deruxtecan for her2+ metastatic colorectal cancer|
Lancet Oncol. Published Online. May 4, 2021
Siena S, et al. Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trialhttps://doi.org/10.1016/S1470-2045(21)00186-8
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.